Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q1 FY24 results · Apr–Jun 2023
Divi's Laboratories reported revenue from operations of ₹1,778.00 crore (down 21.1% from Q1 FY23) and net profit of ₹356.00 crore (down 49.3% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,778.00 | 2,254.52 | −21.1% | 1,950.77 | −8.9% |
| Other income | 81.00 | 88.39 | −8.4% | 66.15 | +22.4% |
| Total income | 1,859.00 | 2,342.91 | −20.7% | 2,016.92 | −7.8% |
| Profit before tax | 492.00 | 851.30 | −42.2% | 466.48 | +5.5% |
| Net profit for the period | 356.00 | 702.01 | −49.3% | 320.97 | +10.9% |
| EPS, basic (₹) | 13.41 | 26.44 | −49.3% | 12.09 | +10.9% |
| Net margin (%) | 20.0 | 31.1 | 16.5 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,730.00 | 2,203.92 | −21.5% | 1,908.17 | −9.3% |
| Other income | 80.00 | 89.99 | −11.1% | 66.15 | +20.9% |
| Total income | 1,810.00 | 2,293.91 | −21.1% | 1,974.32 | −8.3% |
| Profit before tax | 478.00 | 844.05 | −43.4% | 468.04 | +2.1% |
| Net profit for the period | 345.00 | 691.61 | −50.1% | 318.79 | +8.2% |
| EPS, basic (₹) | 12.99 | 26.05 | −50.1% | 12.01 | +8.2% |
| Net margin (%) | 19.9 | 31.4 | 16.7 |
Consolidated
- Filed with BSE
- 14 Aug 2023, 17:08 IST
- Board meeting
- 14 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Aug 2023, 17:08 IST
- Board meeting
- 14 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE